Kurum Yazarı "Demir, Hacer" İçin Listeleme
-
The Comparison of Central Venous Port Catheters in Gastrointestinal Cancer Treatment
Objective: Patients with solid cancers frequently suffer from thrombosis, which is associated with considerable cost, morbidity, and mortality. The infusional chemotherapy regimen, especially in gastrointestinal cancers, ... -
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
Karaçin, Cengiz; Öküzoğlu, Berna; Demirci, Ayşe; Keskinkılıç, Merve; Köse Baytemür, Naziyet; Yılmaz, Funda; Selvi, Oğuzhan; Erdem, Dilek; Avşar, Esin; Paksoy, Nail; Demir, Necla; Sezgin Göksu, Sema; Türker, Sema; Bayram, Ertuğrul; Çelebi, Abdüssamet; Yılmaz, Hatice; Kuzu, Ömer Faruk; Kahraman, Seda; Gökmen, İvo; Sakin, Abdullah; Alkan, Ali; Nayır, Erdinç; Uğraklı, Muzafer; Acar, Ömer; Ertürk, İsmail; Demir, Hacer; Aslan, Ferit; Sönmez, Özlem; Korkmaz, Taner; Celayir, Özde Melisa; Karadağ, İbrahim; Kayıkçıoğlu, Erkan; Şakalar, Teoman; Öktem, İlker Nihat; Eren, Tülay; Erül, Enes; Eylemer Mocan, Eda; Kalkan, Ziya; Yıldırım, Nilgün; Ergün, Yakup; Akagündüz, Baran; Karakaya, Serdar; Kut, Engin; Teker, Fatih; Çakan Demirel, Burçin; Karaboyun, Kubilay; Almuradova, Elvina; Ünal, Olçun Ümit; Oyman, Abdülkerim; Işık, Deniz; Okutur, Kerem; Öztosun, Buğra; Belen Gülbağcı, Burcu; Kalender, Mehmet Emin; Şahin, Elif; Seyyar, Mustafa; Özdemir, Özlem; Selçukbiricik, Fatih; Kanıtez, Metin; Dede, İsa; Gümüş, Mahmut; Gökmen, Erhan; Yaren, Arzu; Menekşe, Serkan; Ebinç, Senar; Aksoy, Sercan; İnanç İmamoğlu, Gökşen; Altınnbaş, Mustafa; Çetin, Bülent; Oyan Uluç, Başak; Er, Özlem; Karadurmuş, Nuri; Erdoğan, Atike Pınar; Artaç, Mehmet; Tanrıverdi, Özgür; Çiçin, İrfan; Şendur, Mehmet Ali Nahit; Oktay, Esin; Bayoğlu, İbrahim Vedat; Paydaş, Semra; Aydıner, Adnan; Kıvrak Salim, Derya; Geredeli, Çağlayan; Yavuzşen, Tuğba; Doğan, Mutlu; Hacıbekiroğlu, İlhan (BioMed Central, 2023)Background There is no standard treatment recommended at category 1 level in international guidelines for subsequent therapy after cyclin-dependent kinase 4/6 inhibitor (CDK4/6) based therapy. We aimed to evaluate which ... -
Does Vitamin D Replacement Alter the Chemotherapy Outcome in Lung Cancer
Objectives: Lung cancer accounts for 20% of cancer-related deaths worldwide. Several studies have shown that Vitamin D levels at the time of diagnosis are prognostic in lung cancer. In this study, we evaluated the relationship ... -
The Effect of Serum Adiponectin and Cortisol Levels on Prognosis in the Patients with Sepsis and Septic Shock
Demir, Hacer; Baloş Törüner, Füsun; Bukan, Neslihan (Kare Publishing, 2021)Objectives: Severe sepsis and septic shock are among the most important causes of death in the intensive care units. Sepsis is a severe stress condition. Hypothalamic-pituitary-adrenal axis plays an important role in ... -
The Effect of The Body Composition to Prognosis in Young Breast Cancer Patients
Beypınar, İsmail; Kaya, Furkan; Demir, Hacer (Akdeniz Üniversitesi, 2021)Objective In cancer patients, the effect of the body composition on prognosis is a new clinical area of interest. In patients with class 2 or 3 obesity (BMI >35), survival was found to be worse control groups in a pooled ... -
The Effect of the Prognostic Nutritional Index on Chemoradiotherapy Response in Lung Cancer
Demir, Hacer; Beypınar, İsmail; Baykara, Meltem (2020)Objective: Lung cancer (LC) is the leading cause of death due to cancer worldwide. The non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) comprise approximately 85% of the malignant lung tumors. The ... -
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study
Özdemir, Özlem; Zengel, Baha; Yıldız, Yaşar; Oyan Uluç, Başak; Çabuk, Devrim; Özden, Ercan; Kıvrak Salim, Derya; Paydaş, Semra; Demir, Atakan; Diker, Ömer; Pilancı, Kezban Nur; Uysal Sönmez, Özlem; Vatansever, Sezai; Doğan, İzzet; Gülmez, Ahmet; Çakar, Burcu; Gürsoy, Pınar; Yıldırım, Mahmut Emre; Ayhan, Murat; Karadurmuş, Nuri; Aykan, Musa Barış; Çevik, Gökçen Tuğba; Şakalar, Teoman; Hacıbekiroğlu, İlhan; Belen Gülbağcı, Burcu; Dinçer, Murat; Bayır Garbioğlu, Duygu; Kemal, Yasemin; Nayır, Erdinç; Taşkaynatan, Halil; Yılmaz, Mesut; Avcı, Okan; Sarı, Murat; Çoban, Ezgi; Atcı, Muhammed Mustafa; Aktürk Esen, Selin; Akın Telli, Tuğba; Karataş, Fatih; İnal, Ali; Demir, Hacer; Önal Kalkan, Nurhan; Yılmaz, Cengiz; Taşlı, Funda; Alacacıoğlu, Ahmet (Lippincott, Williams & Wilkins, 07.06.2022)In our study, we aimed to evaluate the pathological response rates and side effect profile of adding pertuzumab to the treatment of HER2+ locally advanced, inflammatory, or early-stage breast cancer. This study was conducted ... -
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
Karaçin, Cengiz; Öksüzoğlu, Berna; Demirci, Ayşe; Keskinkılıç, Merve; Köse Baytemür, Naziyet; Yılmaz, Funda; Selvi, Oğuzhan; Erdem, Dilek; Avşar, Esin; Paksoy, Nail; Demir, Necla; Sezgin Göksu, Sema; Türker, Sema; Bayram, Ertuğrul; Çelebi, Abdüssamet; Yılmaz, Hatice; Kuzu, Ömer Faruk; Kahraman, Seda; Gökmen, İvo; Sakin, Abdullah; Alkan, Ali; Nayır, Erdinç; Uğraklı, Muzaffer; Acar, Ömer; Ertürk, İsmail; Demir, Hacer; Aslan, Ferit; Sönmez, Özlem; Korkmaz, Taner; Celayir, Özde Melisa; Karadağ, İbrahim; Kayıkçıoğlu, Erkan; Şakalar, Teoman; Öktem, İlker Nihat; Eren, Tülay; Erül, Enes; Eylemer Mocan, Eda; Kalkan, Ziya; Yıldırım, Nilgün; Ergün, Yakup; Akagündüz, Baran; Karakaya, Serdar; Kut, Engin; Teker, Fatih; Çakan Demirel, Burçin; Karaboyun, Kubilay; Almuradova, Elvina; Ünal, Olçun Ümit; Oyman, Abdülkerim; Işık, Deniz; Okutur, Kerem; Öztosun, Buğra; Belen Gülbağcı, Burcu; Kalender, Mehmet Emin; Şahin, Elif; Seyyar, Mustafa; Özdemir, Özlem; Selçukbiricik, Fatih; Kanıtez, Metin; Dede, İsa; Gümüş, Mahmut; Gökmen, Erhan; Yaren, Arzu; Menekşe, Serkan; Ebinç, Senar; Aksoy, Sercan; İnanç İmamoğlu, Gökşen; Altınbaş, Mustafa; Çetin, Bülent; Oyan Uluç, Başak; Er, Özlem; Karadurmuş, Nuri; Erdoğan, Atike Pınar; Artaç, Mehmet; Tanrıverdi, Özgür; Çiçin, İrfan; Şendur, Mehmet Ali Nahit; Oktay, Esin; Bayoğlu, İbrahim Vedat; Paydaş, Semra; Aydıner, Adnan; Kıvrak Salim, Derya; Geredeli, Çağlayan; Yavuzşen, Tuğba; Doğan, Mutlu; Hacıbekiroğlu, İlhan (BioMed Central, 2023)Background: There is no standard treatment recommended at category 1 level in international guidelines for subsequent therapy after cyclin-dependent kinase 4/6 inhibitor (CDK4/6) based therapy. We aimed to evaluate which ... -
Evaluating the effect of tumor size and sidedness on prognosis in stage 2 colon cancer: a retrospective population study
Demir, Hacer; Çağlayan, D; Kaman, O; İnanç, M; Urvay, Semiha; Beypınar, İsmail; Demirci, A; Davarcı, Sena Ece; Araz, M; Baykara, Meltem; Artaç, M; Yıldız, F (Verduci, 2022)OBJECTIVE: In this study, we aimed to evaluate the effect of tumor size and tumor sidedness on prognosis in patients with stage 2 colon cancer. PATIENTS AND METHODS: Data of 501 patients diagnosed with stage 2 colon cancer ... -
Here is the metastasis - find the primary carcinoma for it: a large biopsy study
Özdemir, Çiğdem; Şenol, Yiğit; Baykara, Meltem; Demir, Hacer; Sarıkaya, Yasin (Prusa Medikal Yayıncılık Limited Şirketi, 2023)Objectives: According to estimates, cancer of unknown primary origin (CUP) accounts for approximately 3 to 5% of new cancer cases annually in the United States. With early diagnosis, many CUP patients can achieve long-term ... -
Investigation of the Effect of Tumor Location in Patients with Stage III Colon Cancer Receiving Adjuvant Oxaliplatine-Based Adjuvant Chemotherapy
Urvay, Semiha; Demir, Hacer; Gökyer, Ali; Hacıbekiroğlu, İlhan; Küçükarda, Ahmet; Çakır, Emre; Beypınar, İsmail; Demir, Necla; Civelek, Burak; Özaslan, Ersin (Akad Doktorlar Yayinevi, 2021)Left-sided (LCC) and right-sided (RCC) colon cancers have different prognostic and predictive features in metastatic colon cancers, however there is insufficent data about tumor location in stage III disease. The aim of ... -
Microsatellite instability (MSI) in endometrial cancer; frequency and prognostic significance
Küçük, Alptekin; Demir, Hacer; Özdemir, Çiğdem; Beypınar, İsmail; Baykara, Meltem; Arıöz, Dağıstan Tolga (Derman Medical Publishing, 25.01.2022)Aim: In our study, we aimed to evaluate the frequency of MSI in endometrial cancer and its relationship with prognostic parameters and inflammatory indexes. Material and Methods: MLH1, MSH2, MSH6, and PMS2 mutations were ... -
A New Prognostic Index in Young Breast Cancer Patients
Demir, Hacer; Demirci, Ayşe; Karagöz Eren, Saliha; Beypınar, İsmail; Davarcı, Sena Ece; Baykara, Meltem (College of Physicians and Surgeons Pakistan, 2022)Objective:To evaluate the prognostic role of pan immune-inflammation value (PIV) in young breast cancer patients. Study Design: Descriptive study. Place and Duration of Study: Department of Medical Oncology, Afyon ... -
Prognostic role of pre-operative serum ferritin level in stage 2 colon cancer
Demir, Hacer; Beypınar, İsmail; Urvay, Semiha; Davarcı, Sena Ece; Baykara, Meltem (Verduci, 2021)OBJECTIVE: In this study, we aimed to evaluate the prognostic value of preoperative serum ferritin level in patients with stage 2 colon cancer who underwent curative surgery. PATIENTS AND METHODS: The data of 120 patients ... -
The Real-Life Data of BRAF Mutation on the Treatment of Colorectal Cancer: a TOG Study
Beypınar, İsmail; Demir, Hacer; Sakin, Abdullah; Yapar Taşköylü, Burcu; Sakalar, Teoman; Ergün, Yakup; Korkmaz, Mustafa; Ateş, Öztürk; Eren, Tülay; Turhal, Serdar; Artaç, Mehmet (Springer, 2021)Purpose Colorectal cancer is the third leading diagnosis accounting for nearly 10% of all new cancers worldwide. The distinct features among BRAF mutant colorectal cancers make these tumor groups hard to treat for oncologists. ... -
The relationship between EGFR mutation and metastasis pattern in lung adenocarcinoma
Aim: The metastatic pattern of non-small cell lung cancer (NSCLC) has been described in several studies. Frequent metastatic sites are lung, liver, bone, surrenal, and brain. Hypotheses were speculated to explain the ... -
Survival of patients with metastatic rectum cancer who underwent metastasectomy following conversion chemotherapy sans pelvic radiotherapy: a Turkish oncology group study
Almuradova, Elvina; Yalcin, Suayib; Arıkan, Rukiye; Ayhan, Murat; Demir, Hacer; Çevik, Gökçen Tuğba; Karaca, Mustafa; Petekkaya, İbrahim; Karabulut, Bülent (CA : Cureus, 2023)Background: The management of early rectal cancer is different from that of colon cancer in terms of radiotherapy (RT) requirements or neoadjuvant treatment. It is not clear how the course of rectal cancer differs from ... -
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer
Kahraman, Seda; Erul, Enes; Seyyar, Mustafa; Gümüşay, Özge; Bayram, Ertuğrul; Çakan Demirel, Burçin; Acar, Ömer; Aksoy, Sercan; Kose Baytemur, Naziyet; Şahin, Elif; Çabuk, Devrim; Basaran, Gül; Paydas, Semra; Yaren, Arzu; Güven, Deniz Can; Erdoğan, Atike Pınar; Demirci, Umut; Yaşar, Alper; Bayoğlu, İbrahim Vedat; Hizal, Mutlu; Gülbagci, Burcu; Paksoy, Nail; Davarci, Sena Ece; Yilmaz, Funda; Dogan, Özlem; Oyuncu Orhan, Sibel; Kayikcioglu, Erkan; Aytac, Ali; Keskinkilic, Merve; Eylemer Mocan, Eda; Unal, Olcun Umit; Aydin, Esra; Yucel, Hakan; Isik, Deniz; Eren, Onder; Oyan Uluc, Başak; Özcelik, Melike; Hacibekiroğlu, İlhan; Aydiner, Adnan; Demir, Hacer; Oksuzoğlu, Berna; Cilbir, Ebru; Cubukcu, Erdem; Cetin, Bulent; Oktay, Esin; Erol, Cihan; Okutur, Sadi Kerem; Yildirim, Nilgun; Alkan, Ali; Selcukbiricik, Fatih; Aksoy, Asude; Karakas, Yusuf; Ozkanli, Gulhan; Bozkurt Duman, Berna; Aydın, Dinçer; Dulgar, Özgecan; Er, Muhammed Muhiddin; Teker, Fatih; Yavuzsen, Tugba; Aykan, Musa Barış; İnal, Ali; Iriağac, Yakup; Onal Kalkan, Nurhan; Keser, Murat; Sakalar, Teoman; Menekse, Serkan; Kut, Engin; Bilgin, Burak; Karaoglanoglu, Muge; Sunar, Veli; Ozdemir, Özlem; Turhal, Nazim Serdar; Karadurmuş, Nuri; Yalçın, Bulent; Sendur, Mehmet Ali Nahit (Future Medicine Ltd., 2023)Background: Ribociclib, palbociclib and abemaciclib are currently approved CDK4/6 inhibitors along with aromatase inhibitors as the first-line standard-of-care for patients with hormone receptor-positive, HER2-negative ... -
The View of Turkish Oncologists Regarding MSI Status and Tumor Localization in Stage II and III Colon Cancer
Beypınar, İsmail; Demir, Hacer; Araz, Murat; Baykara, Meltem; Aykan, Nuri Faruk (Springer, 2020)Introduction: Although several clinical factors which show the benefit of adjuvant chemotherapy (AC) in early-stage colon cancer use for evaluating the risk of relapse, there is no consensus on which risk factors are more ...
